Guangjun Sun

Title: Innovations of Guangjun Sun in Pharmaceutical Development

Introduction

Guangjun Sun is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for cancer treatment. His work is characterized by a focus on innovative compounds that target specific biological pathways.

Latest Patents

One of Guangjun Sun's key patents is titled "Tricyclic derivatives inhibitor, preparation method, and applications thereof." This patent describes an inhibitor containing a tricyclic derivative, along with a preparation method and a pharmaceutical composition that includes the inhibitor. The invention is particularly relevant as it serves as a phosphoinositide 3 kinase (PI3K) inhibitor, which is crucial in the treatment of cancer and various diseases or conditions that are mediated by or dependent on PI3K imbalance. Guangjun Sun holds 1 patent related to this innovative work.

Career Highlights

Throughout his career, Guangjun Sun has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Jiangsu Hansoh Pharmaceutical Group Co., Ltd. and Shanghai Hansoh Biomedical Co., Ltd. His experience in these organizations has allowed him to contribute to the advancement of pharmaceutical research and development.

Collaborations

Guangjun Sun has collaborated with several professionals in his field, including Peng Gao and Shaobao Wang. These collaborations have further enriched his research and have led to significant advancements in the development of pharmaceutical compounds.

Conclusion

Guangjun Sun's innovative work in the field of pharmaceuticals, particularly with his patent on tricyclic derivatives, showcases his commitment to advancing cancer treatment. His collaborations and career experiences reflect his dedication to improving healthcare through scientific innovation.